Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy L Ramdial

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Transplantation and Cellular Therapy|March 2, 2024
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell LymphomaMuhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Leukemia|March 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamidePortia Smallbone, Kai Cao, Rima M Saliba, et al.
British Journal of Haematology|October 12, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney functionOmar Mamlouk, Paolo Strati, Lei Feng, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
Leukemia & Lymphoma|October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenanceMahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Blood Advances|August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbiditiesUday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Transplantation and Cellular Therapy|March 2, 2024
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell LymphomaMuhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Leukemia|March 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamidePortia Smallbone, Kai Cao, Rima M Saliba, et al.
British Journal of Haematology|October 12, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney functionOmar Mamlouk, Paolo Strati, Lei Feng, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
Leukemia & Lymphoma|October 23, 2021
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenanceMahmoud R Gaballa, Junsheng Ma, Mark R Tanner, et al.
Blood Advances|August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbiditiesUday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Pageof 3